Talsaclidine, a novel M1-receptor selective muscarinic agonist for cholinergic substitution therapy of Alzheimers disease. Treatment with the selective muscarinic m1 agonist talsaclidine decreases cerebrospinal fluid levels of A beta 42 in patients with Alzheimers disease. Form: Beige Solid Melting Point: 138-142C Solubility: Chloroform, Methanol
Molecular Weight:
201.69
Form:
Beige Solid
* VAT and and shipping costs not included. Errors and price changes excepted
